A dose finding phase II trial of isatuximab (SAR650984, anti-CD38 mAb) as a single agent in relapsed/refractory multiple myeloma Meeting Abstract
| Authors: | Martin, T.; Richter, J.; Vij, R.; Cole, C.; Atanackovic, D.; Zonder, J.; Kaufman, J. L.; Bensinger, W.; Dimopoulos, M. A.; San Miguel, J.; Zimmerman, T.; Lendvai, N.; Hari, P.; Ocio, E. M.; Gasparetto, C.; Kumar, S.; Hsu, K.; Charpentier, E.; Strickland, S. A.; Mikhael, J. |
| Abstract Title: | A dose finding phase II trial of isatuximab (SAR650984, anti-CD38 mAb) as a single agent in relapsed/refractory multiple myeloma |
| Meeting Title: | 57th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 126 |
| Issue: | 23 |
| Meeting Dates: | 2015 Dec 5-8 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2015-12-03 |
| Language: | English |
| ACCESSION: | WOS:000368019001255 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V126.23.509.509 |
| Notes: | Meeting Abstract: 509 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos |
